Schedule 13D ownership disclosure
Fate Therapeutics Inc
Security class unavailable · CUSIP: 31189P102
Event date: 2024-03-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 14.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-038492
- Form type
- SC 13D
- Filer
- FATE THERAPEUTICS INC
- CIK
- CIK 1434316
- Filed
- Mar 25, 2024
- Reporting period
- Mar 21, 2024
- Description
- Schedule 13D beneficial ownership